Results 101 to 110 of about 127,027 (324)
Bleeding related to disturbed fibrinolysis
British Journal of Haematology, 2016 The components and reactions of the fibrinolysis system are well understood. The pathway has fewer reactants and interactions than coagulation, but the generation of a complete quantitative model is complicated by the need to work at the solid‐liquid ...
K. Kolev, C. Longstaff
semanticscholar +1 more source
Clinical &Experimental Allergy, EarlyView.Chronic spontaneous urticaria (CSU) is a debilitating skin disorder with significant impact upon quality of life. Current guidelines advocate stepwise treatment of standard dose antihistamines, high dose antihistamines, omalizumab and ciclosporin.
Katie Ridge +7 more
wiley +1 more source
Safety and Efficacy of Hospital Utilization of Tranexamic Acid in Civilian Adult Trauma Resuscitation [PDF]
, 2020 Introduction: Patients with trauma-induced coagulopathies may benefit from the use of antifibrinolytic agents, such as tranexamic acid (TXA). This study evaluated the safety and efficacy of TXA in civilian adults hospitalized with traumatic hemorrhagic ...
Borger, Rodney +13 more
core
Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease [PDF]
, 1992 Autoimmune chronic active liver disease (ACALD), a major indication for liver transplantation, is associated strongly with antigenic determinants HLA-B8 and DR3.
Block, GD +6 more
core +1 more source
Fibrinolysis: from blood to the brain
Journal of Thrombosis and Haemostasis, 2017 We all know about classical fibrinolysis, how plasminogen activation by either tissue‐type plasminogen activator (t‐PA) or urokinase‐type plasminogen activator (u‐PA) promotes fibrin breakdown, and how this process was harnessed for the therapeutic ...
R. Medcalf
semanticscholar +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Lipoprotein(a) [Lp(a)] is a genetically determined, causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease (CAVD). Despite robust evidence from epidemiological and genetic studies, Lp(a) remains underrecognised in clinical practice due to challenges in measurement, lack of guideline familiarity ...
Alexander C. Razavi +4 more
wiley +1 more source
Türk Kardiyoloji Derneği Arşivi, 2019 Massive pulmonary embolism is a well-known cause of sudden cardiac arrest in the adult population. Systemic fibrinolysis can be a life-saving option. Therapeutic hypothermia is highly recommended for nontraumatic sudden cardiac arrest victims to minimize
Ali Çoner, Tayfun Birtay
doaj +1 more source
Enhanced Fibrinolysis with Magnetically Powered Colloidal Microwheels.
Small, 2017 Thrombi that occlude blood vessels can be resolved with fibrinolytic agents that degrade fibrin, the polymer that forms between and around platelets to provide mechanical stability.
T. Tasci +6 more
semanticscholar +1 more source
Increased packed cell volume alters point of care viscoelastic clotting parameters in horses
Equine Veterinary Journal, Volume 57, Issue 3, Page 766-773, May 2025.Abstract Background Polycythaemia and coagulopathy are identified risk factors for non‐survival in critically ill horses. Assessment of coagulation is recommended for critical care monitoring but may be affected by concurrent polycythaemia. Objective To evaluate the effects of induced polycythaemia on coagulation parameters as measured by a point‐of ...
Rebecca C. Bishop +5 more
wiley +1 more source
Successful treatment of refractory gastrointestinal bleeding by systemic (oral) ankaferd blood stopper in a patient with Glanzmann thrombasthenia [PDF]
, 2015 Background: Glanzmann Thrombasthenia (GT) is a genetic platelet dysfunction and a life threatening disease. Ankaferd Blood Stopper (ABS) is a topical hemostatic agent of herbal origin which has been recently made available for clinical use.
Doğu, Mehmet Hilmi +3 more
core +2 more sources